G Sheill1, E Guinan2, L O Neill3, D Hevey4, J Hussey3. 1. Discipline of Physiotherapy, School of Medicine, Trinity College Centre for Health Sciences, James's Street, Dublin 8, Ireland. sheillg@tcd.ie. 2. School of Medicine, Trinity College Centre for Health Sciences, James's Street, Dublin 8, Ireland. 3. Discipline of Physiotherapy, School of Medicine, Trinity College Centre for Health Sciences, James's Street, Dublin 8, Ireland. 4. School of Psychology, Trinity College Dublin, College Green, Dublin 2, Ireland.
Abstract
PURPOSE: Patients with metastatic cancer can experience debilitating symptoms, which may influence attitudes towards and engagement in physical activity. This study aimed to examine the attitudes of patients living with metastatic prostate cancer towards physical activity. MATERIALS AND METHODS: Semi-structured interviews were completed with male patients living with metastatic prostate cancer. Interviews included eight questions related to patients' attitudes towards physical activity. Content analysis was conducted on the transcribed interview data. Twenty men with metastatic prostate cancer (mean age 71 ± 8.5 years; body mass index 30.19 ± 5.37 kg/cm2) and associated bone metastases (55% with > 2 regions affected) participated in the study. RESULTS: Men's views towards physical activity were coded into the following major themes: (1) barriers to physical activity, (2) benefits of physical activity, (3) a reduction in physical activity levels post diagnosis and (4) social support for physical activity. Symptoms of metastatic prostate cancer and treatment side effects including pain and fatigue negatively influenced activity participation. In addition, many generic barriers to physical activity were described such as bad weather and a lack of suitable facilities for exercising in rural areas. CONCLUSION: Men living with metastatic prostate cancer have unique needs regarding physical activity related to symptoms of both their cancer and cancer treatment. There is a need to increase prompts that encourage those with metastatic prostate cancer to maintain/increase physical activity levels post diagnosis. Given the individualised needs of this patient group, referral to a cancer exercise specialist should be considered for prescription of tailored physical activity programmes. TRIAL REGISTRATION: Clinicaltrials.gov NLM Identifier: NCT02453139.
PURPOSE:Patients with metastatic cancer can experience debilitating symptoms, which may influence attitudes towards and engagement in physical activity. This study aimed to examine the attitudes of patients living with metastatic prostate cancer towards physical activity. MATERIALS AND METHODS: Semi-structured interviews were completed with male patients living with metastatic prostate cancer. Interviews included eight questions related to patients' attitudes towards physical activity. Content analysis was conducted on the transcribed interview data. Twenty men with metastatic prostate cancer (mean age 71 ± 8.5 years; body mass index 30.19 ± 5.37 kg/cm2) and associated bone metastases (55% with > 2 regions affected) participated in the study. RESULTS:Men's views towards physical activity were coded into the following major themes: (1) barriers to physical activity, (2) benefits of physical activity, (3) a reduction in physical activity levels post diagnosis and (4) social support for physical activity. Symptoms of metastatic prostate cancer and treatment side effects including pain and fatigue negatively influenced activity participation. In addition, many generic barriers to physical activity were described such as bad weather and a lack of suitable facilities for exercising in rural areas. CONCLUSION:Men living with metastatic prostate cancer have unique needs regarding physical activity related to symptoms of both their cancer and cancer treatment. There is a need to increase prompts that encourage those with metastatic prostate cancer to maintain/increase physical activity levels post diagnosis. Given the individualised needs of this patient group, referral to a cancer exercise specialist should be considered for prescription of tailored physical activity programmes. TRIAL REGISTRATION: Clinicaltrials.gov NLM Identifier: NCT02453139.
Authors: Eduardo Ferriolli; Richard J E Skipworth; Paul Hendry; Angela Scott; Jacob Stensteth; Max Dahele; Lucy Wall; Carolyn Greig; Marie Fallon; Florian Strasser; Tom Preston; Kenneth C H Fearon Journal: J Pain Symptom Manage Date: 2012-01-24 Impact factor: 3.612
Authors: William F Hartsell; Charles B Scott; Deborah Watkins Bruner; Charles W Scarantino; Robert A Ivker; Mack Roach; John H Suh; William F Demas; Benjamin Movsas; Ivy A Petersen; Andre A Konski; Charles S Cleeland; Nora A Janjan; Michelle DeSilvio Journal: J Natl Cancer Inst Date: 2005-06-01 Impact factor: 13.506
Authors: Max Dahele; Richard J E Skipworth; Lucy Wall; Anne Voss; Tom Preston; Kenneth C H Fearon Journal: J Pain Symptom Manage Date: 2007-03-23 Impact factor: 3.612
Authors: Johan Y Y Ng; Nikos Ntoumanis; Cecilie Thøgersen-Ntoumani; Edward L Deci; Richard M Ryan; Joan L Duda; Geoffrey C Williams Journal: Perspect Psychol Sci Date: 2012-07
Authors: Adam W Glaser; Lorna K Fraser; Jessica Corner; Richard Feltbower; Eva J A Morris; Greg Hartwell; Mike Richards; Richard Wagland Journal: BMJ Open Date: 2013-04-10 Impact factor: 2.692
Authors: Erik D Hanson; Mohamdod Alzer; Jackson Carver; Cameron K Stopforth; Alexander R Lucas; Young E Whang; Matthew I Milowsky; David B Bartlett; Michael R Harrison; Rhonda L Bitting; Allison M Deal; Lee Stoner; A C Hackney; Claudio L Battaglini Journal: Prostate Cancer Prostatic Dis Date: 2022-03-19 Impact factor: 5.554
Authors: J Frikkel; M Beckmann; N De Lazzari; M Götte; S Kasper; J Hense; M Schuler; M Teufel; M Tewes Journal: Support Care Cancer Date: 2021-02-19 Impact factor: 3.603
Authors: Mohammad Keilani; Franz Kainberger; Anna Pataraia; Timothy Hasenöhrl; Barbara Wagner; Stefano Palma; Fadime Cenik; Richard Crevenna Journal: Wien Klin Wochenschr Date: 2019-07-02 Impact factor: 1.704
Authors: Holly E L Evans; Cynthia C Forbes; Corneel Vandelanotte; Daniel A Galvão; Robert U Newton; Gary Wittert; Suzanne Chambers; Ganessan Kichenadasse; Nicholas Brook; Danielle Girard; Camille E Short Journal: Int J Behav Med Date: 2020-09-23
Authors: J Frikkel; M Götte; M Beckmann; S Kasper; J Hense; M Teufel; M Schuler; M Tewes Journal: BMC Palliat Care Date: 2020-03-31 Impact factor: 3.234
Authors: Hao Luo; Daniel A Galvão; Robert U Newton; Ciaran M Fairman; Dennis R Taaffe Journal: Integr Cancer Ther Date: 2019 Jan-Dec Impact factor: 3.279